Not authorised

Product identification

Medicine name:
Aftovaxpur DOE (66) O1 Manisa + O1 BFS + SAT2 Saudi Arabia
Active substance:
  • Foot-and-mouth disease virus, serotype O, strain O1 Manisa, Inactivated
  • Foot-and-mouth disease virus, serotype O, strain O1 BFS, Inactivated
  • Foot-and-mouth disease virus, serotype SAT2, strain Saudi Arabia, Inactivated
Target species:
This information is not available for this product.
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Foot-and-mouth disease virus, serotype O, strain O1 Manisa, Inactivated
    Presentation_strength:? 6 PD50 Reference:Hse Index:0
  • Foot-and-mouth disease virus, serotype O, strain O1 BFS, Inactivated
    Presentation_strength:? 6 PD50 Index:11
  • Foot-and-mouth disease virus, serotype SAT2, strain Saudi Arabia, Inactivated
    Presentation_strength:? 6 PD50 Index:12
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA04
Authorisation status:
  • Surrendered
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 19/03/2024
Download
Bulgarian (PDF)
Published on: 19/03/2024
Croatian (PDF)
Published on: 19/03/2024
Czech (PDF)
Published on: 19/03/2024
Danish (PDF)
Published on: 19/03/2024
Dutch (PDF)
Published on: 19/03/2024
Estonian (PDF)
Published on: 19/03/2024
Finnish (PDF)
Published on: 19/03/2024
French (PDF)
Published on: 19/03/2024
German (PDF)
Published on: 19/03/2024
Greek (PDF)
Published on: 19/03/2024
Hungarian (PDF)
Published on: 19/03/2024
Icelandic (PDF)
Published on: 19/03/2024
Italian (PDF)
Published on: 19/03/2024
Latvian (PDF)
Published on: 19/03/2024
Lithuanian (PDF)
Published on: 19/03/2024
Maltese (PDF)
Published on: 19/03/2024
Norwegian (PDF)
Published on: 19/03/2024
Polish (PDF)
Published on: 19/03/2024
Portuguese (PDF)
Published on: 19/03/2024
Romanian (PDF)
Published on: 19/03/2024
Slovak (PDF)
Published on: 19/03/2024
Slovenian (PDF)
Published on: 19/03/2024
Spanish (PDF)
Published on: 19/03/2024
Swedish (PDF)
Published on: 19/03/2024

ema-puar-aftovaxpur-v-2292-var-ii-0001-en.pdf

English (PDF)
Published on: 6/02/2023
Download

ema-puar-aftovaxpur-v-2292-var-ii-0009-en.pdf

English (PDF)
Published on: 6/02/2023
Download

ema-puar-aftovaxpur-v-2292-par-en.pdf

English (PDF)
Published on: 6/02/2023
Download

Source URL: https://medicines.health.europa.eu/veterinary/600000001296